Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion

Kidney International

Volumn 67, Issue 5, 2005, Pages 1753-1761

  Cugini, Daniela ^b   Azzollini, Nadia ^b   Gagliardini, Elena ^b   Cassis, Paola ^b   Bertini, Riccardo ^b   Colotta, Francesco ^b   Noris, Marina ^b   Remuzzi, Giuseppe ^b   Benigni, Ariela ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b NONE

Author keywords

CXCR2 inhibitor; Granulocytes; Ischemia reperfusion; Repertaxin; Transplantation

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; CREATININE; INTERLEUKIN 8; MESSENGER RNA; RECEPTOR BLOCKING AGENT; REPERTAXIN; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; GENE EXPRESSION; GRAFT DYSFUNCTION; GRANULOCYTE; ISCHEMIA; KIDNEY DISEASE; KIDNEY GRAFT; MALE; MULTIPLE DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 17744382390     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00272.x     Document Type: Article

References (36)

1. BONVENTRE J, WEINBERG JM: Recent advances in the phatophysiology of ischemic acute renal failure. J Am Soc Nephrol 14:2199-2210, 2003
2. CARPENTER CB: Long-term failure of renal transplants: Adding insult to injury. Kidney Int (Suppl 50):S40-S44, 1995
3. SMOKES DA, HALLORAN P: Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol 155:1831-1840, 1996
4. LU CY: Ischemia, injury and renal allograft rejection. Curr Opin Nephrol Hypertens 5:107-110, 1996
5. SUTTON TA, FISHER CJ, MOLITORIS BA: Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 62:1539-1549, 2002
6. SEKIDO N, MUKAIDA N, HARADA A, et al: Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 365:654-657, 1993
7. BAGGIOLINI M, DEWALD B, MOSER B: Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv Immunol 55:97-179, 1994
8. BAGGIOLINI M, LOETSCHER P, MOSER BV: Interleukin-8 and the chemokine family. Int J Immunopharmacol 2:103-108, 1995
9. RAINGER GE, FISHER AC, NASH GB: Endothelial-borne platelet-activating factor and interleukin-8 rapidly immobilize rolling neutrophils. Am J Physiol 272:H114-H122, 1997
10. WELBOURN CR, GOLDMAN G, PATERSON IS, et al: Pathophysiology of ischemia reperfusion injury: Central role of the neutrophil. Br J Surg 78:651-655, 1991
11. SAFIRSTEIN R, MEGYESI J, SAGGI SJ, et al: Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am J Physiol 261:F1095-F1101, 1991
12. MIZUTANI A, OKAJIMA K, UCHIBA M, NOGUCHI T: Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 95:3781-3787, 2000
13. JO N, WU GS, RAO NA: Upregulation of chemokine expression in the retinal vasculature in ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 44:4054-4060, 2003
14. MORITA K, MIURA M, PAOLONE DR, et al: Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J Immunol 167:2979-2984, 2001
15. MISTER M, NORIS M, SZYMCZUK J, et al: Propionyl-L-carnitine prevents renal function deterioration due to ischemia/reperfusion. Kidney Int 61:1064-1078, 2002
16. BERTINI R, ALLEGRETTI M, BIZZARRI C, et al: A new class of non-competitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injury. PNAS 101:11791-11796, 2004
17. SOUZA DG, BERTINI R, VIEIRA AT, et al: Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury. Br J Pharmacol 143:132-142, 2004
18. NORIS M, AZZOLLINI N, MISTER M, et al: Peripheral donor leukocytes prolong survival of rat renal allografts. Kidney Int 56:1101-1112, 1999
19. PERICO N, CATTANEO D, SAYEG MH, REMUZZI G: Delayed graft function in kidney transplantation. Lancet 364:1814-1827, 2004
20. THADHANI R, PASCUAL M, BONVENTRE JV: Medical progress: Acute renal failure. N Engl J Med 334:1448-1460, 1996
21. CHIAO H, KOHDA Y, MCLEROY P, et al: α-Melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 99:1165-1172, 1997
22. MACKAY CR: Chemokine: Immunology's high impact factors. Nature Immunol 2:95-101, 2001
23. DEFORGE LE, PRESTON AM, TAKEUCHI E, et al: Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem 268:25568-25576, 1993
24. DEFORGE LE, FANTONE JC, KENNEY JS, REMICK DG: Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. J Clin Invest 90:2123-2129, 1992
25. OPPENHEIM JJ, ZACHARIAE CO, MUKAIDA N, MATSUSHIMA K: Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 9:617-648, 1991
26. IVEY CL, WILLIAMS FM, COLLINS PD, et al: Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. J Clin Invest 95:2720-2728, 1995
27. WEI M, KUUKASJÄRVI P, LAURIKKA J, et al: Cytokine responses in patients undergoing coronary artery bypass surgery after ischemic preconditioning. Scand Cardiovasc J 35:142-146, 2001
28. DE GREEF KE, YSEBAERT DK, GHIELLI M, et al: Neutrophils and acute ischemia-reperfusion injury. J Nephrol 11:110-122, 1998
29. HELLBERG PO, KÄLLSKOG TO: Neutrophil-mediated post-ischemic tubular leakage in the rat kidney. Kidney Int 36:555-561, 1989
30. KELLY KJ, WILLIAMS WW, COLVIN RB, et al: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 97:1056-1063, 1996
31. TAKADA M, NADEAU KC, SHAW GD, et al: The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 99:2682-2690, 1997
32. FARRAR CA, WANG Y, SACKS SH, ZHOU W: Independent pathways of P-selectin and complement-mediated renal ischemia/reperfusion injury. Am J Pathol 164:133-141, 2004
33. SOUZA DG, CARA DC, CASSALI GD, et al: Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat. Br J Pharmacol 131:1800-1808, 2000
34. SOUZA DG, COUTINHO SF, SILVEIRA MR, et al: Effects of a BLT receptor antagonist on local and remote reperfusion injuries after transient ischemia of the superior mesenteric artery in rats. Eur J Pharmacol 403:121-128, 2000
35. PALLER MS: Effect of neutrophil depletion on ischemic renal injury in the rat. J Lab Clin Med 113:379-386, 1989
36. THORNTON MA, WINN R, ALPERS CE, ZAGER RA: An evaluation of the neutrophil as a mediator of in vivo renal ischemic-reperfusion injury. Am J Pathol 135:509-515, 1989